Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001091818-22-000045
Filing Date
2022-05-05
Accepted
2022-05-05 14:29:24
Documents
35
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 AMENDED QTR REPORT MARCH 31, 2022 bfnh-20220331.htm   iXBRL 10-Q/A 197417
2 CERTIFICATION ex311.htm EX-31.1 4761
3 CERTIFICATION ex312.htm EX-31.2 4958
4 CERTIFICATION ex321.htm EX-32.1 2028
5 CERTIFICATION ex322.htm EX-32.2 1933
11 bfnhlogo2019001.jpg GRAPHIC 21193
  Complete submission text file 0001091818-22-000045.txt   1319386

Data Files

Seq Description Document Type Size
6 bfnh-20220331.xsd EX-101.SCH 13246
7 bfnh-20220331_cal.xml EX-101.CAL 13252
8 bfnh-20220331_def.xml EX-101.DEF 62424
9 bfnh-20220331_lab.xml EX-101.LAB 127282
10 bfnh-20220331_pre.xml EX-101.PRE 67947
29 EXTRACTED XBRL INSTANCE DOCUMENT bfnh-20220331_htm.xml XML 58714
Mailing Address 2020 GENERAL BOOTH BLVD SUITE 230 VIRGINIA BEACH VA 23454
Business Address 2020 GENERAL BOOTH BLVD SUITE 230 VIRGINIA BEACH VA 23454 757-306-6090
BIOFORCE NANOSCIENCES HOLDINGS, INC. (Filer) CIK: 0001310488 (see all company filings)

EIN.: 852138858 | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-51074 | Film No.: 22895544
SIC: 3826 Laboratory Analytical Instruments